[Cost aspects. Proving possible savings first, then implementation].
D000897:Anti-Ulcer Agents / Q000191:economics*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D016568:Drugs, Generic / Q000191:economics*; D005858:Germany; D006801:Humans; D054328:Proton Pump Inhibitors
D000897:Anti-Ulcer Agents; D016568:Drugs, Generic; D054328:Proton Pump Inhibitors